Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Trouvez La Carte De Cr\u00e9dit Id\u00e9ale Pour Vos Besoins En Belgique - 2Closets for Your Room: Plan and Utility Features
- 3From record warming to rusting rivers, 2025 Arctic Report Card shows a region transforming faster than expected
- 4The Best Competitors of the 21st Hundred years
- 5Avoid Slam: Clearing the Street for the Eventual fate of Standard Size Trucks
- Key Training: Picking a Significant for Monetary Achievement
- In blow to Lula, Brazil Congress revives controversial environmental bill
- Grasping the Course of Evacuation and Extradition in U.S. Migration
- US EPA will reassess safety of herbicide paraquat, says its chief
- People with depression can treat themselves at home with new device
- Reviving Your Home with Nutritious Indoor Plants
- 12 times rockets and spacecraft crashed and burned in 2025
- 7 Well known Vacation spots In The US
- Mother and Stepson Rescued After Being Swept Over 6 Miles in Paddleboarding Mishap
